facioscapulohumeral muscular dystrophy Clinical Trials in Nijmegen
3 recruitingNijmegen, Netherlands
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
facioscapulohumeral muscular dystrophyFascioscapulohumeral Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+14 more
Avidity Biosciences, Inc.200 enrolled46 locationsNCT07038200
Recruiting
Ten Year Follow-up in FSHD: the FOCUS 3 Study
FSHD - Facioscapulohumeral Muscular Dystrophy
Radboud University Medical Center200 enrolled1 locationNCT06911190
Recruiting
Not Applicable
An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice50 enrolled9 locationsNCT06079567